微流控
3D打印
液晶显示器
制作
光致聚合物
纳米技术
炸薯条
微流控芯片
吞吐量
芯片上器官
高分辨率
材料科学
计算机硬件
计算机科学
光电子学
聚合物
电信
病理
复合材料
地质学
医学
遥感
替代医学
无线
聚合
作者
Houda Shafique,Vahid Karamzadeh,Geunyong Kim,Molly L. Shen,Yonatan Morocz,Ahmad Sohrabi Kashani,David Juncker
出处
期刊:Lab on a Chip
[Royal Society of Chemistry]
日期:2024-01-01
卷期号:24 (10): 2774-2790
被引量:79
摘要
The fabrication of microfluidic devices has progressed from cleanroom manufacturing to replica molding in polymers, and more recently to direct manufacturing by subtractive (e.g., laser machining) and additive (e.g., 3D printing) techniques, notably digital light processing (DLP) photopolymerization. However, many methods require technical expertise and DLP 3D printers remain expensive at a cost ∼15-30 K USD with ∼8 M pixels that are 25-40 μm in size. Here, we introduce (i) the use of low-cost (∼150-600 USD) liquid crystal display (LCD) photopolymerization 3D printing with ∼8-58 M pixels that are 18-35 μm in size for direct microfluidic device fabrication, and (ii) a poly(ethylene glycol) diacrylate-based ink developed for LCD 3D printing (PLInk). We optimized PLInk for high resolution, fast 3D printing and biocompatibility while considering the illumination inhomogeneity and low power density of LCD 3D printers. We made lateral features as small as 75 μm, 22 μm-thick embedded membranes, and circular channels with a 110 μm radius. We 3D printed microfluidic devices previously manufactured by other methods, including an embedded 3D micromixer, a membrane microvalve, and an autonomous capillaric circuit (CC) deployed for interferon-γ detection with excellent performance (limit of detection: 12 pg mL-1, CV: 6.8%). We made PLInk-based organ-on-a-chip devices in 384-well plate format and produced 3420 individual devices within an 8 h print run. We used the devices to co-culture two spheroids separated by a vascular barrier over 5 days and observed endothelial sprouting, cellular reorganization, and migration. LCD 3D printing together with tailored inks pave the way for democratizing access to high-resolution manufacturing of ready-to-use microfluidic and organ-on-a-chip devices by anyone, anywhere.
科研通智能强力驱动
Strongly Powered by AbleSci AI